The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Development of a Multimarker Assay for Early Detection of Ovarian Cancer
Open accessAbstract
Purpose: Early detection of ovarian cancer has great promise to improve clinical outcome. Patients and Methods: Ninety-six serum biomarkers were analyzed in sera from healthy women and from patients with ovarian cancer, benign pelvic tumors, and breast, colorectal, and lung cancers, using multiplex xMAP bead-based immunoassays. A Metropolis algorithm with Monte Carlo simulation (MMC) was used for analysis of the data. Results: A training set, including sera from 139 patients with early-stage ovarian cancer, 149 patients with late-stage ovarian cancer, and 1,102 healthy women, was analyzed with MMC algorithm and cross validation to identify an optimal biomarker panel discriminating early-stage cancer from healthy controls. The four-biomarker panel providing the highest diagnostic power of 86% sensitivity (SN) for early-stage and 93% SN for late-stage ovarian cancer at 98% specificity (SP) was comprised of CA-125, HE4, CEA, and VCAM-1. This model was applied to an independent blinded validation set consisting of sera from 44 patients with early-stage ovarian cancer, 124 patients with late-stage ovarian cancer, and 929 healthy women, providing unbiased estimates of 86% SN for stage I and II and 95% SN for stage III and IV disease at 98% SP. This panel was selective for ovarian cancer showing SN of 33% for benign pelvic disease, SN of 6% for breast cancer, SN of 0% for colorectal cancer, and SN of 36% for lung cancer. Conclusion: A panel of CA-125, HE4, CEA, and VCAM-1, after additional validation, could serve as an initial stage in a screening strategy for epithelial ovarian cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Equation of State Calculations by Fast Computing Machines
Metropolis, N., Rosenbluth, A. W., Rosenbluth, M. N., Teller, A. H., & Teller, E. (1953) · The Journal of Chemical Physics · doi:10.1063/1.1699114 · Cited by 37,192
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T., & Thun, M. J. (2008) · CA: A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0010 · Cited by 10,188
Monte Carlo Statistical Methods
Kim, H. (2000) · Technometrics · doi:10.1080/00401706.2000.10485722 · Cited by 5,508
Monte Carlo Statistical Methods
Robert, C. P., & Casella, G. (2004) · Springer Texts in Statistics · doi:10.1007/978-1-4757-4145-2 · Cited by 4,271
A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian Cancer
Bast, R. C., Klug, T. L., John, E. S., Jenison, E., Niloff, J. M., Lazarus, H., Berkowitz, R. S., Leavitt, T., Griffiths, C. T., Parker, L., et al. (1983) · New England Journal of Medicine · doi:10.1056/nejm198310133091503 · Cited by 2,135
Self-citationMonte Carlo: Concepts, Algorithms, and Applications
Wasserstein, R. L. (1997) · Technometrics · doi:10.1080/00401706.1997.10485133 · Cited by 1,790
The CA 125 tumour-associated antigen: a review of the literature
Jacobs, I., & Bast, R. C. (1989) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a136832 · Cited by 955
Self-citationZhang, Z., Bast, R. C., Yu, Y., Li, J., Sokoll, L. J., Rai, A. J., Rosenzweig, J. M., Cameron, B., Wang, Y. Y., Meng, X.-Y., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0746 · Cited by 934
Self-citationMonte Carlo: Concepts, Algorithms, and Applications
(1996) · Journal of Computational and Applied Mathematics · doi:10.1016/s0377-0427(97)80822-9 · Cited by 795
The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma.
Hellström, I., Raycraft, J., Hayden-Ledbetter, M. S., Ledbetter, J. A., Schummer, M., McIntosh, M. W., Drescher, C. W., Urban, N. D., & Hellström, K. E. (2003) · PubMed · Cited by 711
Cited by
CA125 and Ovarian Cancer: A Comprehensive Review
Charkhchi, P., Cybulski, C., Gronwald, J., Wong, F. O., Narod, S. A., & Akbari, M. R. (2020) · Cancers · doi:10.3390/cancers12123730 · Cited by 602
Functional Biomarkers of Depression: Diagnosis, Treatment, and Pathophysiology
Schmidt, H. D., Shelton, R. C., & Duman, R. S. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.151 · Cited by 474
Jokerst, J. V., Cole, A. J., Van de Sompel, D., & Gambhir, S. S. (2012) · ACS Nano · doi:10.1021/nn304347g · Cited by 397
Stacking machine learning algorithms for biomarker-based preoperative diagnosis of a pelvic mass
Shaw, R., Lokshin, A. E., Miller, M. C., Messerlian-Lambert, G., & Moore, R. G. (2022) · Cancers · doi:10.3390/cancers14051291 · Cited by 16
Self-citation
Metadata
- Authors
- Yurkovetsky, Z., Skates, S., Lomakin, A., Nolen, B., Pulsipher, T., Modugno, F., Marks, J., Godwin, A., Gorelik, E., Jacobs, I., Menon, U., Lu, K., Badgwell, D., Bast, R. C., & Lokshin, A. E.
- Venue
- Journal of Clinical Oncology
- Published
- 2010-05-01
- Volume
- 28
- Issue
- 13
- Pages
- 2159-2166
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2145803449
- Cited by
- 274
- References
- 55
- FWCI
- 35.15
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Development of a Multimarker Assay for Early Detection of Ovarian Cancer. https://app.cochat.ai/papers/10.1200/jco.2008.19.2484
- The paper
- Yurkovetsky, Z., Skates, S., Lomakin, A., Nolen, B., Pulsipher, T., Modugno, F., Marks, J., Godwin, A., Gorelik, E., Jacobs, I., Menon, U., Lu, K., Badgwell, D., Bast, R. C., & Lokshin, A. E. (2010). Development of a Multimarker Assay for Early Detection of Ovarian Cancer. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2008.19.2484
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.